JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4926
CALL
Ross Stores
ROST
$73B
| $424K | ﹤0.01% |
2,800
-49,300
| -95% | -$7.25M |
2024 Q2
2 quarters
|
|
4927
Vident US Bond Strategy ETF
VBND
$507M
| $423K | ﹤0.01% |
9,852
-60
| -0.6% | -$2.63K |
2024 Q2
2 quarters
|
|
|
BLUE
4928
DELISTED
bluebird bio
BLUE
| $423K | ﹤0.01% |
50,726
+19,633
| +63% | +$172K |
2014 Q3
41 quarters
|
|
4929
PUT
Papa John's
PZZA
$640M
| $423K | ﹤0.01% |
10,300
-100
| -1% | -$4.91K |
2024 Q3
1 quarter
|
|
4930
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$571M
| $421K | ﹤0.01% |
12,401
-6,167
| -33% | -$213K |
2021 Q1
15 quarters
|
|
4931
Empire Petroleum
EP
$109M
| $420K | ﹤0.01% |
55,223
+30,839
| +126% | +$183K |
2022 Q2
10 quarters
|
|
4932
Aegon
AEG
$12.5B
| $419K | ﹤0.01% |
71,189
+30,296
| +74% | +$190K |
2013 Q2
46 quarters
|
|
4933
CALL
Opko Health
OPK
$1.16B
| $418K | ﹤0.01% |
284,400
| – | – |
2024 Q2
2 quarters
|
|
4934
ArriVent BioPharma
AVBP
$1.39B
| $418K | ﹤0.01% |
15,685
+3,240
| +26% | +$93K |
2024 Q1
3 quarters
|
|
4935
Puma Biotechnology
PBYI
$491M
| $418K | ﹤0.01% |
136,897
+88,404
| +182% | +$257K |
2013 Q2
46 quarters
|
|
|
CTNM
4936
Contineum Therapeutics
CTNM
$494M
| $416K | ﹤0.01% |
28,426
+25,934
| +1,041% | +$411K |
2024 Q2
2 quarters
|
|
|
GOLD
4937
Gold.com Inc
GOLD
$1.23B
| $415K | ﹤0.01% |
15,158
-20,049
| -57% | -$680K |
2020 Q2
18 quarters
|
|
4938
Avantis International Small Cap Value ETF
AVDV
$20.1B
| $413K | ﹤0.01% |
6,353
-100,999
| -94% | -$6.8M |
2023 Q2
6 quarters
|
|
4939
Symbotic
SYM
$5.62B
| $411K | ﹤0.01% |
17,349
+375
| +2% | +$10.7K |
2021 Q4
12 quarters
|
|
4940
StealthGas
GASS
$351M
| $411K | ﹤0.01% |
72,770
+44,354
| +156% | +$259K |
2024 Q3
1 quarter
|
|
4941
Invesco RAFI Strategic US ETF
IUS
$966M
| $410K | ﹤0.01% |
8,259
+593
| +8% | +$30.1K |
2023 Q2
6 quarters
|
|
|
TWFG
4942
TWFG Inc
TWFG
$317M
| $410K | ﹤0.01% |
+13,315
| New | +$414K |
2024 Q4
0 quarters
|
|
|
SAGE
4943
CALL
DELISTED
Sage Therapeutics
SAGE
| $407K | ﹤0.01% |
+75,000
| New | +$459K |
2024 Q4
0 quarters
|
|
|
SAGE
4944
PUT
DELISTED
Sage Therapeutics
SAGE
| $407K | ﹤0.01% |
+75,000
| New | +$459K |
2024 Q4
0 quarters
|
|
4945
PUT
Plug Power
PLUG
$2.65B
| $406K | ﹤0.01% |
190,700
-94,300
| -33% | -$206K |
2024 Q1
3 quarters
|
|
4946
Fidelity Emerging Markets Multifactor ETF
FDEM
$596M
| $404K | ﹤0.01% |
16,001
+4,898
| +44% | +$128K |
2024 Q2
2 quarters
|
|
4947
TELA Bio
TELA
$51.5M
| $404K | ﹤0.01% |
133,666
+133,327
| +39,329% | +$375K |
2022 Q3
9 quarters
|
|
4948
Karooooo
KARO
$1.85B
| $403K | ﹤0.01% |
8,934
+8,445
| +1,727% | +$357K |
2023 Q3
5 quarters
|
|
4949
Seer Inc
SEER
$125M
| $403K | ﹤0.01% |
174,322
-1,032
| -0.6% | -$2.26K |
2020 Q4
16 quarters
|
|
|
CAN
4950
Canaan Creative
CAN
$256M
| $402K | ﹤0.01% |
+196,339
| New | +$332K |
2024 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.